financetom
Business
financetom
/
Business
/
Cabot Fiscal Q4 Adjusted Earnings, Revenue Decline; Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cabot Fiscal Q4 Adjusted Earnings, Revenue Decline; Shares Fall
Nov 3, 2025 2:56 PM

05:31 PM EST, 11/03/2025 (MT Newswires) -- Cabot (CBT) reported fiscal Q4 adjusted net income late Monday of $1.70 per diluted share, down from $1.80 a year earlier.

Analysts polled by FactSet expected $1.68.

Revenue for the quarter ended Sept. 30 was $899 million, down from $1 billion a year earlier.

Analysts expected $960.7 million.

For fiscal 2026, the company expects adjusted EPS of $6 to $7.

Analysts are looking for $7.82.

Shares fell over 5% in recent after-hours trade.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fox, DISH Network Strike Distribution Deal for Fox Nation
Fox, DISH Network Strike Distribution Deal for Fox Nation
Mar 12, 2024
01:53 PM EDT, 03/12/2024 (MT Newswires) -- Fox's (FOX) Fox Nation direct-to-consumer subscription streaming service expanded its distribution to Dish Network's (DISH) Dish TV and Sling TV, Fox Nation said Tuesday. Financial details weren't disclosed. Beginning mid-March, Dish subscribers can add Fox Nation for $5.99 per month, while the service will also be available for the same price to all...
Sector Update: Consumer
Sector Update: Consumer
Mar 12, 2024
01:46 PM EDT, 03/12/2024 (MT Newswires) -- Consumer stocks were higher Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.5% and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 0.9%. Redbook US same-store sales rose by 3% from a year earlier in the week ended March 9 after a 3.1% year-over-year increase in the previous...
Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing
Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing
Mar 12, 2024
01:45 PM EDT, 03/12/2024 (MT Newswires) -- Thomas Richard Kassberg, Chief Business Officer & Executive Vice President, on March 11, 2024, sold 11,509 shares in Ultragenyx Pharmaceutical ( RARE ) for $574,644. Following the Form 4 filing with the SEC, Kassberg has control over a total of 252,823 shares of the company, with 252,823 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1515673/000095017024029780/xslF345X03/ownership.xml...
Top Midday Gainers
Top Midday Gainers
Mar 12, 2024
01:56 PM EDT, 03/12/2024 (MT Newswires) -- Regulus Therapeutics ( RGLS ) said Tuesday that the second cohort of patients in a phase 1b study of RGLS8429 for Autosomal Dominant Polycystic Kidney Disease showed clear evidence of a mechanistic dose-response over placebo. Shares surged past 86% in recent trading as intraday trading volume soared to over 146 million from a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved